Choice of implant in total hip arthroplasty for sickle cell disease patients

el-Hazmi MA, Warsy AS, al-Swailem AR, al-Swailem AM, Bahakim HM (1996) Sickle cell gene in the population of Saudi Arabia. Hemoglobin 20(3):187–198

Gelpi AP (1979) Benign sickle cell disease in Saudi Arabia: survival estimate and population dynamics. Clin Genet 15(4):307–310

Weatherall DJ, Clegg JB (2001) Inherited haemoglobin disorders: an increasing Global health problem. Bull world health organization 79:704–712

Akinyoola AL, Adediran IA, Asaleye CM (2007) Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 14(3):217–220

Sadat-Ali M (1993) Avascular necrosis of femoral head in sickle cell disease: an integrated classification. Clin Orth Rel Res 290:200–205

Moran MC, Huo MH, Garvin KL, Pellicci PM, Salvati EA (1993) Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop 294:140–148

Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD (1989) Total hip replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg 71:465–470

Acurio MT, Friedman RJ (1992) Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br 74(3):367–371

Ilyas I, Moreau P (2002) Simultaneous bilateral total hip arthroplasty in sickle cell disease. J Artrhoplasty 17:441–445

Epps C, Castro O (1978) Complications of total hip replacement in sickle cell disease. Orthop Trans 2:236–237

Gunderson C, D’Ambrosia RD, Shoji H (1977) Total hip replacement in patients with sickle-cell disease. J Bone Joint Surg 59:760–762

Hanker GJ, Amstutz HC (1988) Osteonecrosis of the hip in the sickle-cell disease: treatment and complications. J Bone Joint Surg 70:499–506

Hickman JM, Lachiewicz PF (1997) Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies. Role of cementless components. J Arthroplasty 12(4):420–425

Vichinsky EP, Neumayr LD, Haberkern C et al (1999) The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol 62(3):129–138

Sanjay BK, Moreau PG (1996) Bipolar hip replacement in sickle cell disease. Int Orthop 20(4):222–226

Callaghan JJ, Salvati EA, Pellicci PM, Wilson PD, Ranawat CS (1985) Results of revision for mechanical failure after cemented total hip replacement 1979–1982. A two to five year follow up. J bone Joint Surg 67(7):1074–1085

Harris WH (1969) Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51(4):737–755

DeLee JG, Charnley J (1976) Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res 121:20–32

Gruen TA, McNeice GM, Amstutz HC (1997) “Models of failure” of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop 141:17–27

Lins RE, Barnes BC, Callaghan JJ, Mair SD, McCollum DE (1993) Evaluation of uncemented total hip arthroplasty in patients with avascular necrosis of the femoral head. Clin Orthop Relat Res 297:168–173

Engh CA, Massin P, Suthers KE (1990) Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res 257:107–128

Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assn 53:457–481

LaPorte DM, Mont MA, Hungerford DS (1999) Proximally porous-coated ingrowth prostheses: limits of use. Orthopedics 22(12):1154–1160, quiz 1161-2

Al-Mousawi F, Malki A, Al-Aradi A, Al-Bagali M, Al-Sadadi A, Booz MM (2002) Total hip replacement in sickle cell disease. Int Orthop 26(3):157–161

Ali SA (1970) Milder variant of sickle-cell disease in Arabs in Kuwait associated with unusually high level of foetal haemoglobin. Br J Haematol 19(5):613–619

Hawker H, Neilson H, Hayes RJ, Serjeant GR (1982) Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. Br J Haematol 50(1):29–34

McAuley JP, Szuszczewicz ES, Young A, Engh CA Sr (2004) Total hip arthroplasties in patients fifty years and younger. Clin Orthop Relat Res 418:119–125

Chandler HP, Reineck FT, Wixson RL, McCarthy JC (1981) Total hip replacement in patients younger than thirty years old. A five-year follow-up study. J Bone Joint Surg Am 63(9):1426–1434